Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic TargetLuika Timmerman, Joe W. Gray, Kornélia Polyák et al.|Cancer Cell|2013Cited by 571